UBS AM’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
+249,500
| New | +$246K | ﹤0.01% | 2545 |
|
|
2023
Q3 | – | Sell |
-111,482
| Closed | -$177K | – | 2619 |
|
|
2023
Q2 | $177K | Hold |
111,482
| – | – | ﹤0.01% | 2585 |
|
|
2023
Q1 | $177K | Buy |
111,482
+39,787
| +55% | +$63.3K | ﹤0.01% | 2585 |
|
|
2022
Q4 | $447K | Buy |
+71,695
| New | +$447K | ﹤0.01% | 2218 |
|
|
2021
Q4 | – | Sell |
-33,476
| Closed | -$403K | – | 2870 |
|
|
2021
Q3 | $403K | Hold |
33,476
| – | – | ﹤0.01% | 2562 |
|
|
2021
Q2 | $708K | Buy |
33,476
+6,240
| +23% | +$132K | ﹤0.01% | 2389 |
|
|
2021
Q1 | $764K | Buy |
27,236
+4,235
| +18% | +$119K | ﹤0.01% | 2206 |
|
|
2020
Q4 | $598K | Hold |
23,001
| – | – | ﹤0.01% | 2232 |
|
|
2020
Q3 | $855K | Sell |
23,001
-207
| -0.9% | -$7.69K | ﹤0.01% | 1905 |
|
|
2020
Q2 | $1.19M | Buy |
23,208
+3,904
| +20% | +$200K | ﹤0.01% | 1727 |
|
|
2020
Q1 | $609K | Sell |
19,304
-1,866
| -9% | -$58.8K | ﹤0.01% | 1899 |
|
|
2019
Q4 | $1.26M | Buy |
21,170
+88
| +0.4% | +$5.25K | ﹤0.01% | 1801 |
|
|
2019
Q3 | $773K | Buy |
21,082
+3,594
| +21% | +$132K | ﹤0.01% | 2078 |
|
|
2019
Q2 | $814K | Buy |
17,488
+2,498
| +17% | +$116K | ﹤0.01% | 1985 |
|
|
2019
Q1 | $602K | Buy |
14,990
+1,097
| +8% | +$44K | ﹤0.01% | 2034 |
|
|
2018
Q4 | $639K | Buy |
13,893
+4,493
| +48% | +$207K | ﹤0.01% | 1897 |
|
|
2018
Q3 | $417K | Buy |
9,400
+3,300
| +54% | +$146K | ﹤0.01% | 2159 |
|
|
2018
Q2 | $239K | Sell |
6,100
-60,674
| -91% | -$2.38M | ﹤0.01% | 2400 |
|
|
2018
Q1 | $4.83M | Buy |
66,774
+1,480
| +2% | +$107K | ﹤0.01% | 1162 |
|
|
2017
Q4 | $4.3M | Buy |
65,294
+25,396
| +64% | +$1.67M | ﹤0.01% | 1167 |
|
|
2017
Q3 | $2M | Buy |
39,898
+700
| +2% | +$35.1K | ﹤0.01% | 1405 |
|
|
2017
Q2 | $1.81M | Sell |
39,198
-147,954
| -79% | -$6.85M | ﹤0.01% | 1403 |
|
|
2017
Q1 | $6.61M | Buy |
+187,152
| New | +$6.61M | 0.01% | 975 |
|
|
2015
Q3 | – | Sell |
-5,700
| Closed | -$466K | – | 2679 |
|
|
2015
Q2 | $466K | Buy |
5,700
+1,600
| +39% | +$131K | ﹤0.01% | 2105 |
|
|
2015
Q1 | $380K | Buy |
+4,100
| New | +$380K | ﹤0.01% | 2125 |
|